|

Trifluridine/tipiracil (TAS-102) plus bevacizumab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Ruijin Hospital1

Indications

  • TAS 1021
  • Third-line and Beyond Therapy1
  • Bevacizumab1
  • Colo-rectal Cancer1
  • Cancer1

Other1 trial

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.